ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,269Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 3593

$1.21M Total Retail Price of All Prescriptions

Rank: 91 out of 3593

587 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 587 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

22% of this provider’s 587 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 18,118 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

36 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
FUROSEMIDE 846 761 1 9
LEVOTHYROXINE SODIUM 649 581 2 4
HYDROCODONE-ACETAMINOPHEN 594 470 S3 3 7
OMEPRAZOLE 487 431 4 5
LISINOPRIL 470 422 5 2
METOPROLOL TARTRATE 440 374 6 8
POTASSIUM CHLORIDE 419 380 7 24
SIMVASTATIN 375 330 8 1
AMLODIPINE BESYLATE 359 354 9 3
CARVEDILOL 299 253 10 23
METFORMIN HCL 288 213 11 6
GABAPENTIN 277 192 12 16
NAPROXEN 259 198 13 68
PRAVASTATIN SODIUM 255 216 14 13
NAMENDA 243 218 15 50
RISPERIDONE 241 208 16 83
MELOXICAM 237 213 17 29
TRAMADOL HCL 234 209 18 17
JANTOVEN 230 204 19 169
DIOVAN 229 217 20 46
FENTANYL 229 185 S2 20 137
CITALOPRAM HBR 224 188 22 25
BACLOFEN 199 96 23 109
RANITIDINE HCL 197 168 24 27
ZOLPIDEM TARTRATE 192 170 25 12
ISOSORBIDE MONONITRATE ER 191 177 26 61
DONEPEZIL HCL 189 168 27 31
METOPROLOL SUCCINATE 185 172 28 19
HYDROCHLOROTHIAZIDE 179 148 29 10
AZITHROMYCIN 173 161 30 34
SPIRONOLACTONE 169 152 31 86
DILTIAZEM 24HR CD 167 150 32 173
DIGOXIN 163 138 33 58
CLOPIDOGREL 154 135 34 30
NEXIUM 150 105 35 36
CIPROFLOXACIN HCL 149 131 36 52
TAMSULOSIN HCL 141 123 37 33
WARFARIN SODIUM 141 134 37 18
PANTOPRAZOLE SODIUM 138 107 39 45
CLONIDINE HCL 137 115 40 41
PENTOXIFYLLINE 137 127 40 149
CRESTOR 130 99 42 21
SERTRALINE HCL 128 84 43 28
PREDNISONE 124 111 44 49
GLIPIZIDE 119 118 45 40
AMOX TR-POTASSIUM CLAVULANATE 119 112 45 138
PLAVIX 118 107 47 42
ESCITALOPRAM OXALATE 117 108 48 71
IPRATROPIUM-ALBUTEROL 117 114 48 154
OXYCODONE-ACETAMINOPHEN 116 105 S2 50 93
QUETIAPINE FUMARATE 115 79 51 89
AMOXICILLIN 113 95 52 128
LYRICA 112 77 53 105
RAMIPRIL 110 101 54 92
ALLOPURINOL 109 102 55 35
FAMOTIDINE 107 94 56 70
POLYETHYLENE GLYCOL 3350 105 61 57 143
ROPINIROLE HCL 102 100 58 144
GLIPIZIDE XL 99 93 59 179
TRAZODONE HCL 96 56 60 53
MUPIROCIN 95 69 61 132
CARBIDOPA-LEVODOPA 94 94 62 135
TRIAMTERENE-HCTZ 93 85 63 66
PHENYTOIN SODIUM EXTENDED 92 70 64 165
PAROXETINE HCL 92 86 64 62
VOLTAREN 90 84 66 85
DIOVAN HCT 90 83 66 76
METOCLOPRAMIDE HCL 88 72 68 145
HALOBETASOL PROPIONATE 88 78 68 443
LEVEMIR 86 74 70 193
MIRTAZAPINE 84 82 71 64
ACTOS 82 69 72 133
OXYBUTYNIN CHLORIDE 81 80 73 104
NITROGLYCERIN PATCH 80 80 74 212
NOVOLIN R 80 63 74 140
LANTUS 77 69 76 57
LEVOFLOXACIN 76 66 77 116
LOSARTAN POTASSIUM 75 71 78 14
CELEBREX 74 50 79 100
ADVAIR DISKUS 73 53 80 47
PERMETHRIN 71 62 81 347
VERAPAMIL ER 68 68 82 99
NITROSTAT 68 59 82 224
AMITRIPTYLINE HCL 67 46 R 84 90
DILTIAZEM HCL 67 35 84 250
ATORVASTATIN CALCIUM 66 59 86 15
KLOR-CON M10 64 56 87 211
SULFAMETHOXAZOLE-TRIMETHOPRIM 64 55 87 102
AMITIZA 64 52 87 349
MEGACE ES 60 57 R 90 373
FINASTERIDE 60 54 90 79
OXYBUTYNIN CHLORIDE ER 58 56 92 175
PREMARIN 57 56 R 93 204
PHENYTOIN 57 46 93 326
JANUVIA 57 52 93 81
HYDROXYZINE HCL 56 56 R 96 196
ACETAMINOPHEN-CODEINE 56 52 S3 96 153
VESICARE 56 54 96 205
FLUTICASONE PROPIONATE 55 46 99 32
VENLAFAXINE HCL 55 51 99 267
TRIAMCINOLONE ACETONIDE 55 54 99 119
GLIPIZIDE ER 54 51 102 101
SPIRIVA 54 44 102 87
SEROQUEL XR 53 53 104 199
PROAIR HFA 53 50 104 54
SINGULAIR 52 41 106 77
LEXAPRO 52 51 106 184
PROMETHAZINE HCL 51 37 R 108 142
LEVEMIR FLEXPEN 51 30 108 228
HYDROMORPHONE HCL 51 0 S2 108 171
LOVASTATIN 51 51 108 20
NASONEX 50 48 112 192
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.